Catalyst Wire Dossier Catalyst Wire Dossier

AURN001

· Aurion Biotech
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AURN001, covering 2025-01-28 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction [Phase 3]

See pricing